Executive Director, Lifecycle Lead
- Role
- Product
- Experience
- C-Level
- Employment
- Full-time
Open to US only. Set where you work from to check your eligibility.
No BS summary
Executive Director-level lifecycle leader for strategic biopharma development programs, from early research and clinical development through validation, launch, and lifecycle management. Remote role, West Coast preferred.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible. Title: Executive Director, Lifecycle Lead Location: Remote (West Coast preferred) Reporting to: Chief Medical & Development Officer
The Executive Director, Lifecycle Lead is responsible for leading one or more strategic development programs across the full product lifecycle—from early research and clinical development through process validation (PV/PPQ), commercial readiness, launch, and lifecycle management.
This role serves as the cross-functional leader accountable for defining and executing integrated asset strategies that maximize program value and align with Kyverna’s portfolio and corporate objectives. The Lifecycle Lead partners closely with Research, Translational Sciences, Clinical Development, Regulatory Affairs, Technical Operations, Manufacturing & Supply, Quality, Medical Affairs, Commercial, and Business Development.
What you'll do
- Leading one or more strategic development programs across the full product lifecycle—from early research and clinical development through process validation (PV/PPQ), commercial readiness, launch, and lifecycle management.
- Defining and executing integrated asset strategies that maximize program value and align with Kyverna’s portfolio and corporate objectives.
- Partnering closely with Research, Translational Sciences, Clinical Development, Regulatory Affairs, Technical Operations, Manufacturing & Supply, Quality, Medical Affairs, Commercial, and Business Development.
Benefits
- Eligible for bonus
- Eligible for benefits
- Participation in Company’s stock plan
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.